v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities    
Net loss $ (1,757,611) $ (1,649,703)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 123,504 70,124
Change in fair value of warrant liability (2,257) (48,096)
Changes in operating assets and liabilities:    
Advances on research and development contract services 49,087 (321,431)
Prepaid expenses and other current assets 125,403 171,229
Accounts payable and accrued expenses 76,870 (51,390)
Research and development contract liabilities 44,980
Accrued legal settlement (414,989)
Net cash used in operating activities (1,385,004) (2,199,276)
Cash flows from financing activities    
Proceeds from issuance of common shares from ATM, net of costs 347,549
Proceeds from sale of common stock and warrants in public offering, net of offering costs 4,352,792 1,504,339
Exercise of pre-funded warrants 436
Net cash provided by financing activities 4,700,341 1,504,775
Net increase (decrease) in cash 3,315,337 (694,501)
Cash, beginning of period 3,325,131 3,026,569
Cash, end of period 6,640,468 2,332,068
Supplemental information    
Income taxes paid
Noncash investing and financing activities    
Options issued to settle accrued bonus $ 46,183 $ 77,400